Cover Image


Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis

出版商 MIC - Market Intelligence & Consulting Institute 商品編碼 333059
出版日期 內容資訊 英文 30 Pages
Back to Top
血糖儀:技術,商務機會,專利分析 Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis
出版日期: 2015年06月15日 內容資訊: 英文 30 Pages


第1章 技術開發

  • 侵入性血糖儀
  • 非侵入性血糖儀

第2章 專利探勘

  • 專利資料庫的選擇
  • 搜尋關鍵字的確認
  • 資料選擇
  • 資料分析
  • 趨勢分析
    • 文字探勘
    • 資料探勘
    • 研究開發 (R&D) 的相對強度
    • 專利發展分析的結果
    • 專利指數分析的結果

第3章 市場預測






Product Code: RPT15061501

Amid the global economy growth, the number of consumers with diabetes is rising annually in several countries and regions as result of unhealthy diets with high sugar and calorie intakes. Having a blood glucose meter is evidenced to help diabetes patients effectively control blood glucose levels, thereby reducing the risk of complications associated with diabetes. This report provides an overview of invasive and non-invasive blood glucose meters and market outlook and the relative R&D strength analysis of top 30 companies; examines strategic and patent deployments of several established players in the industry such as Dexcom, Medtronic, Abbott, Baxter and Roche Diagnostics.

Table of Contents

1.Technology Development

  • 1.1 Invasive Blood Glucose Meter
  • 1.2 Non-invasive Blood Glucose Meter

2.Patent Mining

  • 2.1 Selecting a Patent Database
  • 2.2 Identifying Search Keywords
  • 2.3 Data Selection
  • 2.4 Data Analysis
  • 2.5 Analysis of Trends
    • 2.5.1 Text Mining
    • 2.5.2 Data Mining
    • 2.5.3 Relative R&D Strength
    • 2.5.4 Result of Patent Deployment Analysis
    • 2.5.5 Results of Patent Index Analysis

3.Market Outlook

MIC Perspecitve


Glossary of Terms

List of Companies

List of Topics

Overview of the blood glucose meters, including invasive and non-invasive types

Major technology fields and sectors identified using the data mining technique; also included are top 30 assignees and their R&D strength ranking

A brief outlook for the sales volume and value of the worldwide blood glucose meter market from 2015 to 2019

Worldwide blood glucose meter market share by sector, and by field type

Analysis of 30 blood glucose meter assignees' deployment in 28 corresponding technology fields and also included is matrix analysis of 10 most important blood glucose meter patents

List of Figures

  • Figure 1: Illustration of Blood Glucose Meters
  • Figure 2: Search Flow for Blood Glucose Meter Patents
  • Figure 3: Blood Glucose Meters' Distribution Share by Sector
  • Figure 4: Blood Glucose Meters' Distribution Share by Field Type

List of Tables

  • Table 1: Comparison of Invasive and Non-invasive Blood Glucose Meters
  • Table 2: Key Technology Fields Identified by Text Mining for Blood Glucose Meters
  • Table 3: R&D Strength Ranking of Top 30 Assignees in the Field of Blood Glucose Meters
  • Table 4: Blood Glucose Meter Assignees' Technology Field Deployment Analysis
  • Table 5: Blood Glucose Meter Assignees' Technology Field Deployment Analysis (continued)
  • Table 6: Top 10 Assignees of Blood Glucose Meters
  • Table 7: Matrix Analysis of 10 Most Important Blood Glucose Meter Patents

Companies covered

Abbott, Alfred E. Mann Foundation for Science Research, Animas Corporation, Baxter, Bayer, Cardiac Pacemakers Inc., Cercacor Laboratories, Dexcom, E. Heller & Company, East West Bank, Eyesense AG, GLT Acquisition Corp., Glumetrics Inc., Hudson Bay Master Fund, Isense Corporation, Legacy Good Samaritan Hospital and Medical Center, Lifescan Inc, Markwell Medical Institute, Medisense, Medtronic, Midcap Funding, National Institutes of Health, Oxygen Biotherapeutics, Panasonic, Roche Diagnostics, Sensors for Medicine and Science, Siemens, Silver James H, Therasense, University of New Mexico, Vivomedical Inc., Xoetronics LLC

Back to Top